|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online April 18, 2001 as doi:10.1096/fj.00-0780fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


,




2
* Department of Neurochemistry and Neurotoxicology, Arrhenius Laboratories, Stockholm University, S-10691 Stockholm, Sweden;
Estonian Biocentre, EE-51010, Tartu, Estonia;
Section for Natural Sciences, Södertörns Högskola (University College), S-141 04 Huddinge, Sweden;
Department of Biochemistry, Arrhenius Laboratories, Stockholm University, S-10691 Stockholm, Sweden;
¶ Institute of Zoology and Hydrobiology, Tartu University, EE-51014, Tartu, Estonia; and the

Harold L. Dorris Neurological Research Center, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037, USA
2Correspondence: Harold L. Dorris Neurological Research Ctr., Department of Neuropharmacology, The Scripps Research Inst.,10550 N. Torrey Pines Rd., Mail SR-307, La Jolla, CA 92037, USA. E-mail: ulangel{at}scripps.edu
SPECIFIC AIMS
Peptide-mediated delivery of hydrophilic macromolecules has gained more and more attention in recent years. Transduction of protein of interest into cells by the help of peptides can serve as a good alternative to protein microinjection and protein expression from plasmids in transfected cells.
In this study, we investigated whether a small cell-penetrating peptide transportan is able to deliver whole intact proteins across the plasma membrane into the cell interior. We also studied the possibility of applying peptide-mediated transport for noncovalent complexes and confirmed that unfolding of proteins is not obligatory for delivery into cells.
PRINCIPAL FINDINGS
1. Transportan is able to deliver medium-sized proteins into cells
The green fluorescent protein (GFP), a widely exploited tag, was
used to estimate the ability of transportan to deliver intact proteins
into cells. We coupled recombinant GFP to transportan (TP) via a
disulfide bridge formed between an extra cysteine at the GFP carboxyl
terminus and Cys-
-NH-Lys13 of TP (Fig. 1A
). The transportan-GFP conjugate was added directly to the
cell culture medium, and after 1060 min the GFP fluorescence was
located in the interior of the cells (Fig. 2
). Most of the GFP fluorescence was located to cytoplasmic membranes and
to a lesser extent to the plasma membrane. The intensity and
localization of GFP fluorescence in the plasma membrane were not
affected by treatment of cells with reducing agents, suggesting that
the disulfide bond of the construct and the construct itself are
extracellularly inaccessible, and hence must be located inside the
cells or buried in the membrane.
|
|
2. GFP is internalized in an intact folded state
Native GFP has a very tight barrel-shaped structure that has to be
preserved for fluorescence. The fluorescence is detectable at all
stages of TP-GFP internalization: in the solution, at the plasma
membrane, and inside the cells (Fig. 2)
, suggesting that GFP in the
TP-GFP construct does not unfold during passage over the plasma
membrane.
3. Large proteins coupled to transportan are delivered into cells
Not only medium-sized conjugates of transportan with proteins
(e.g., GFP-TP) are able to translocate into cells. Coupling transportan
to avidin-TRITC conjugate by a chemical cross-link results in a
cell-translocating protein derivative (Fig. 1C
). Cellular
uptake of transportan-avidin-TRITC construct was rapid: 5 min
incubation with the construct led to accumulation of the label in the
plasma membrane of COS-7 cells. After 30 min, avidin was detectable
inside the cells. Coupling of transportan molecules to protein gives
cell-translocating ability to as large proteins as antibodies.
4. The covalent bond between the transport peptide and a cargo is
not necessary for protein delivery
The efficient delivery of a cargo molecule into the cells is
considered to be achieved only when coupled covalently to the transport
peptide. On the other hand, the possibility of using a noncovalent
complex of the transport peptide and a cargo molecule for delivery has
not been much studied so far.
A fluorescent derivative of streptavidin (e.g., streptavidin-Texas red)
itself or in a combination with a cell-penetrating peptide is not able
to translocate from the tissue culture medium into the cell interior
(Fig. 3E
). Simultaneous addition of biotinylated transportan and
Texas red-labeled streptavidin (Fig. 1)
leads to the formation of
strong complexes and to the insertion of complexes into the plasma
membrane of COS-7 cells in 510 min. Later, these complexes shift more
inside the cells and finally concentrate in the perinuclear area (Fig. 3A
, B
, C
, D
).
|
Preformation of the complex between biotinyl-transportan and streptavidin-TxR before applying to the cells for 515 min slightly increased the initial velocity of the uptake, but the general pattern of localization and distribution of complexes inside the cells remains unchanged.
The delivered streptavidin is confined to vesicular structures in COS-7
cells (Fig. 3A
, B
, C
, D
). Complexes of biotinyl-transportan with
streptavidin-gold conjugate (SA-Au) reside in vesicular structures in
COS-7 cells that are either surrounded by membrane or not, but are also
diffuse in the cytoplasm, as judged by electron microscopy (Fig. 3G
). Localization of delivered SA-Au outside the membrane
surrounded vesicles suggests that peptide-mediated uptake of proteins
can also involve processes other than absorptive endocytosis. Moreover,
lowering temperature below 18°C abolishes endocytosis, but the uptake
of biotinyl-transportan complexes with streptavidin-Texas red is not
completely suppressed even at 04°C (Fig. 3F
).
5. Transportan is able to deliver large complexes into the cell
interior
Avidin and streptavidin form extremely strong complexes with
biotin and biotinylated molecules. Labeled streptavidin was efficiently
delivered into the cells by biotinylated transportan, most probably in
the form of a complex. It is still unclear how stable the complexes of
a transport peptide with a protein have to be and how large these
proteins can be in order to be efficiently translocated into cells.
Monoclonal anti-biotin antibodies with a molecular mass
150 kDa are
also conveyed into the cells by biotinylated transportan (Fig. 3H
), demonstrating that the complex of peptide and protein
does not have to be extra strong. The size of the proteins to be
delivered intracellularly by transportan probably is not limited to a
molecular mass of 150 kDa. The particle size of streptavidin conjugate
with colloidal gold corresponds to a globular protein with a molecular
mass of
1 MDa; in a complex with biotinyl-transportan, this
conjugate translocates efficiently in a noninvasive way into living
cells in culture.
CONCLUSIONS
Cell-penetrating peptides have been used to noninvasively transport small cargoes like oligonucleotides and peptides into the living cells for 45 years. Recently, peptide-mediated cellular delivery of whole proteins was demonstrated. Transportan along with Tat and Antennapedia-derived peptides conveys proteins into living cells.
How these cell-penetrating peptides or protein-transducing domains enter the cell is largely unknown. Their internalization is not mediated by endocytosis, chiral receptors, or proteins in general and is not dependent on temperature or ATP. There is only one model (formation of inverted micelle) proposed for penetration of Antennapedia-derived peptide into cell, but it has not yet been proved experimentally.
Even less is known about the mechanism of peptide-mediated protein transport. Formation of pores in the plasma membrane of a cell by penetrating peptides, thereby enabling direct access to cell interior for proteins, can be excluded since mixing of transport peptide with a cargo protein does not lead to protein translocation into the cells. Moreover, formation of even short-living pores by cell-penetrating peptides has never been detected.
Proteins that are coupled to transport peptide by a chemical bond are
efficiently delivered cellularly. However, the covalent bond between a
cargo protein and the penetrating peptide is not necessary, since the
cells also internalize noncovalent transportanprotein complexes. Very
large complexes/conjugates that correspond to
1 MDa protein can be
conveyed into living cells by transportan. The peptideprotein
complexes are not internalized by the cells by endocytosis alone;
other, less understood mechanisms must be involved: the complexes
translocate into cells at low temperatures and a significant fraction
of the protein delivered inside the cells is localized outside the
membrane-surrounded vesicles.
Some peptides enable transport of large proteins and protein complexes into cells in a noninvasive way, which can be used to regulate the finely tuned cellular processes. Unfolding of protein by denaturation is not necessary for cellular delivery; inside the cells, at least a fraction of transported protein is located outside the membrane surrounded vesicles and is not targeted into lysosomes. Accordingly, transportan enables transduction of whole proteins into the cells, where they retain their intactness and activity (at least partially).
Our data suggest that transportan is able to deliver proteins and other hydrophilic macromolecules into mammalian cells and demonstrate its potential as powerful cellular delivery vector for scientific and therapeutic purposes.
FOOTNOTES
1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.00-0780fje ; to cite this article, use FASEB J. (April 18, 2001) 10.1096/fj.00-0780fje ![]()
This article has been cited by other articles:
![]() |
C. I. Lopez, S. A. Belmonte, G. A. De Blas, and L. S. Mayorga Membrane-permeant Rab3A triggers acrosomal exocytosis in living human sperm FASEB J, December 1, 2007; 21(14): 4121 - 4130. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Yandek, A. Pokorny, A. Floren, K. Knoelke, U. Langel, and P. F. F. Almeida Mechanism of the Cell-Penetrating Peptide Transportan 10 Permeation of Lipid Bilayers Biophys. J., April 1, 2007; 92(7): 2434 - 2444. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jain, S. C. Chauhan, A. P. Singh, G. Venkatraman, D. Colcher, and S. K. Batra Penetratin Improves Tumor Retention of Single-Chain Antibodies: A Novel Step toward Optimization of Radioimmunotherapy of Solid Tumors Cancer Res., September 1, 2005; 65(17): 7840 - 7846. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |